[Retracted] Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl₄-Induced Liver Cirrhosis

Table 1

Changes in body weight and organ weight of CCl₄-induced cirrhosis-related cardiac hypertrophy.

	A^a	B	C	D	E
	(𝑛=8)	(𝑛=8)	(𝑛=8)	(𝑛=8)	(𝑛=8)
BW (g)	425 ± 16.475	402 ± 8.920	385 ± 6.547	388 ± 10.823	420 ± 19.272
WHW (g)	1.041 ± 0.015	1.173 ± 0.031*	0.975 ± 0.023^#	1.089 ± 0.026	1.023 ± 0.015^#
LVW (g)	0.813 ± 0.010	0.898 ± 0.018*	0.745 ± 0.028^#	0.777 ± 0.021	0.767 ± 0.023^#
WHW/BW (%)	2.467 ± 0.095	2.918 ± 0.093*	2.535 ± 0.065^#	2.813 ± 0.067	2.461 ± 0.101^#
LVW/BW (%)	1.922 ± 0.050	2.233 ± 0.045*	1.933 ± 0.054^#	2.190 ± 0.062	1.844 ± 0.085^#
LVW/WHW (%)	0.781 ± 0.011	0.767 ± 0.012	0.764 ± 0.020	0.779 ± 0.015	0.751 ± 0.030

^a Group A is given olive oil and water, Group B is given CCl₄ and water, Group C is given CCl₄ and 0.02 g/kg of OGE, Group D is given CCl₄ and 0.04 g/kg of OGE, and Group E is given CCl₄ and 0.2 g/kg of silymarin. The individual severity rates in rats were expressed as mean ± SE. BW: body weight; WHW: whole heart weight; LVW: left ventricle weight. *Significant differences from Group A, P < 0.05. ^#Significant differences from Group B, P < 0.05.